Qida Hu

2.8k total citations · 1 hit paper
55 papers, 2.4k citations indexed

About

Qida Hu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Qida Hu has authored 55 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 15 papers in Oncology and 11 papers in Surgery. Recurrent topics in Qida Hu's work include RNA Interference and Gene Delivery (11 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Nanoparticle-Based Drug Delivery (9 papers). Qida Hu is often cited by papers focused on RNA Interference and Gene Delivery (11 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Nanoparticle-Based Drug Delivery (9 papers). Qida Hu collaborates with scholars based in China, Singapore and Hong Kong. Qida Hu's co-authors include Guping Tang, Paul K. Chu, Xueli Bai, Ping Yuan, Tingbo Liang, Wei Chen, Jun Li, Qi Zhang, Tingbo Liang and Qihan Fu and has published in prestigious journals such as Advanced Materials, Accounts of Chemical Research and Biomaterials.

In The Last Decade

Qida Hu

53 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cyclodextrin-Based Host–Guest Supramolecular Nanoparticles for Delivery: From Design to Applications

2014 441 citations Qida Hu, Guping Tang et al. profile →

Peers

Countries citing papers authored by Qida Hu

Since Specialization

Citations

This map shows the geographic impact of Qida Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qida Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qida Hu more than expected).

Fields of papers citing papers by Qida Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qida Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qida Hu. The network helps show where Qida Hu may publish in the future.

Co-authorship network of co-authors of Qida Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Qida Hu. A scholar is included among the top collaborators of Qida Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qida Hu. Qida Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	STING-activating pyroptotic nanoparticles for in situ pancreatic cancer vaccination and immunotherapy 2025 ·Science Bulletin ·Shiyi Shao, (unknown), Yuxuan Chen, Meng Wang, (unknown), Jianwei Wang, (unknown), Xinya Li, Yao Zhang, Ping Yuan, Qida Hu, Tingbo Liang	0
2	Engineered a Gemcitabine Nano‐Prodrug Targeting Desmoplastic Pancreatic Tumor with Dual Enhancement of Penetration Dynamics 2025 ·Small ·Qida Hu, Fu Zhang, Bowen Li, Piaopiao Jin, Junming Huang, Zhuo Yao, Xinyu Zhao, Shiyi Shao, Meng Wang, Ping Yuan, Tingbo Liang	2
3	A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy 2023 ·Acta Biomaterialia ·Yuan Chen, Zhuo Yao, Peilian Liu, Qida Hu, Yong Huang, (unknown), Fu Zhang, Honglin Tang, Tao Wan, Ping Yuan, Bowen Li	54
4	A tumor microenvironment-stimuli responsive nano-prodrug for overcoming gemcitabine chemoresistance by co-delivered miRNA-21 modulator 2023 ·Biomedical Materials ·(unknown), Zhuo Yao, Piaopiao Jin, (unknown), Qida Hu, (unknown), Risheng Que, Tingbo Liang	7
5	Situs inversus totalis with local metastasis of gallbladder carcinoma and variation of the common hepatic artery 2022 ·BMC Gastroenterology ·Cheng Zhang, Bo Zhang, Haifeng Huang, Qida Hu, (unknown), Qingsong Yu, (unknown), (unknown), (unknown)	4
6	Tumor-triggered personalized microRNA cocktail therapy for hepatocellular carcinoma 2020 ·Biomaterials Science ·Shiyi Shao, Qida Hu, Wangteng Wu, Meng Wang, Junming Huang, Xinyu Zhao, Guping Tang, Tingbo Liang	21
7	A PEGylated megamer-based microRNA delivery system activatable by stepwise microenvironment stimulation 2019 ·Chemical Communications ·Wangteng Wu, Qida Hu, Meng Wang, Shiyi Shao, Xinyu Zhao, Hongzhen Bai, Junming Huang, Guping Tang, Tingbo Liang	15
8	Reverting chemoresistance of targeted agents by a ultrasoluble dendritic nanocapsule 2019 ·Journal of Controlled Release ·Qida Hu, Wangteng Wu, Meng Wang, Shiyi Shao, Piaopiao Jin, Qi Chen, Hongzhen Bai, Xinyu Zhao, Junming Huang, Jianwei Wang, Guping Tang, Tingbo Liang	5
9	Impact of national Human Development Index on liver cancer outcomes: Transition from 2008 to 2018 2019 ·World Journal of Gastroenterology ·Shiyi Shao, Qida Hu, Meng Wang, Xinyu Zhao, Wangteng Wu, Junming Huang, Tingbo Liang	16
10	Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis 2016 ·Cancer Research ·Long‐Yun Ye, Wei Chen, Xueli Bai, Xingyuan Xu, Qi Zhang, Xuefeng Xia, Xu Sun, Guogang Li, Qida Hu, Qihan Fu, Tingbo Liang	233
11	A redox-sensitive, oligopeptide-guided, self-assembling, and efficiency-enhanced (ROSE) system for functional delivery of microRNA therapeutics for treatment of hepatocellular carcinoma 2016 ·Biomaterials ·Qida Hu, Kai Wang, Xu Sun, Yang Li, Qihan Fu, Tingbo Liang, Guping Tang	39
12	Inhibition of Protein Phosphatase 2A Enhances Cytotoxicity and Accessibility of Chemotherapeutic Drugs to Hepatocellular Carcinomas 2014 ·Molecular Cancer Therapeutics ·Xueli Bai, Qi Zhang, Long‐Yun Ye, Qida Hu, Qihan Fu, Xiao Zhi, Wei Su, (unknown), Tao Ma, Wei Chen, Shangzhi Xie, (unknown), Tingbo Liang	31
13	Restoration of chemosensitivity by multifunctional micelles mediated by P-gp siRNA to reverse MDR 2014 ·Biomaterials ·Jie Shen, Qiwen Wang, Qida Hu, Yongbing Li, Guping Tang, Paul K. Chu	71
14	Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling 2014 ·Oncogene ·(unknown), (unknown), (unknown), Feng Liang, Xu Sun, Ye Chen, Qida Hu, (unknown), Wen-Hui Su, (unknown), Zhengping Zhuang, (unknown)	72
15	Rapamycin enhances cetuximab cytotoxicity by inhibiting mTOR-mediated drug resistance in mesenchymal hepatoma cells 2014 ·Cancer Biology & Therapy ·Wei Chen, Qida Hu, Xuefeng Xia, Chao Liang, Hao Liu, Qi Zhang, Tao Ma, Liang Feng, Tingbo Liang	14
16	Inhibition of protein phosphatase 2A sensitizes pancreatic cancer to chemotherapy by increasing drug perfusion via HIF-1α-VEGF mediated angiogenesis 2014 ·Cancer Letters ·Xueli Bai, Xiao Zhi, Qi Zhang, Feng Liang, Wei Chen, Chao Liang, Qida Hu, Xu Sun, Zhengping Zhuang, Tingbo Liang	50
17	Wnt/β-catenin signaling enhances hypoxia-induced epithelial–mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling 2013 ·Carcinogenesis ·Qi Zhang, Xueli Bai, Wei Chen, Tao Ma, Qida Hu, Chao Liang, Shangzhi Xie, (unknown), Liqiang Hu, (unknown), Tingbo Liang	203
18	Serotonin promotes the proliferation of serum-deprived hepatocellular carcinoma cells via upregulation of FOXO3a 2013 ·Molecular Cancer ·Chao Liang, Wei Chen, Xiao Zhi, Tao Ma, Xuefeng Xia, Hao Liu, Qi Zhang, Qida Hu, Yun Zhang, Xueli Bai, Tingbo Liang	72
19	In vivo treatment of tumors using host-guest conjugated nanoparticles functionalized with doxorubicin and therapeutic gene pTRAIL 2011 ·Biomaterials ·Hui Fan, Qida Hu, Fu‐Jian Xu, Wenquan Liang, Guping Tang, Wantai Yang	76
20	Polyethylenimine-cyclodextrin-tegafur conjugate shows anti-cancer activity and a potential for gene delivery 2011 ·Journal of Zhejiang University SCIENCE B ·Qida Hu, Hui Fan, (unknown), Qingqing Wang, Guping Tang	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact